Lv3
316 积分 2023-01-15 加入
Evaluation and management of rheumatoid arthritis-associated interstitial lung disease
6天前
已关闭
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
8天前
已完结
The therapeutic potential for JAK inhibitors for immune-related adverse events from checkpoint inhibitors: a review of the literature
8天前
已完结
Steroid-sparing strategies for managing immune-related adverse events
8天前
已完结
Contemporary Management of Immune Checkpoint Inhibitor-related Adverse Events
8天前
已关闭
Immune‐related adverse events in immune checkpoint inhibitor therapy for cancer
8天前
已完结
Autoimmune-related adverse events induced by immune checkpoint inhibitors
8天前
已完结
Prevention and management of cutaneous immune‐related adverse events: EADV Task Force statement
8天前
已完结
Rheumatic adverse events of immune checkpoint inhibitors in cancer immunotherapy
8天前
已完结
NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024
8天前
已完结
皖公网安备34019202002308
